Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 296-120-8 | CAS number: 92257-31-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Carcinogenicity
Administrative data
- Endpoint:
- carcinogenicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- disregarded due to major methodological deficiencies
- Study period:
- 1972
- Reliability:
- 3 (not reliable)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- This study is considered to be reliability 3 since it was performed at Industrial Biotest Laboratories prior to the implementation of GLP and during a time period where the conduct, quality and reliability of studies performed at this lab was brought into question.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 972
- Report date:
- 1972
Materials and methods
- GLP compliance:
- no
Test material
- Reference substance name:
- 2-Naphthalenol, 1-[[4-(phenylazo)phenyl]azo]-, ar-heptyl ar',ar''-Me derivs.
- EC Number:
- 296-120-8
- EC Name:
- 2-Naphthalenol, 1-[[4-(phenylazo)phenyl]azo]-, ar-heptyl ar',ar''-Me derivs.
- Cas Number:
- 92257-31-3
- Molecular formula:
- Not applicable
- IUPAC Name:
- 2-Naphthalenol, 1-[2-[4-(2-phenyldiazenyl)phenyl]diazenyl]-, ar-heptyl ar',ar''-Me derivatives *
- Test material form:
- not specified
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- Swiss
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- Experimental Animals:
Young adult female Swiss white mice of the Charles River CD-i strain were used in this investigation. The animals were selected for use in this test following a pretest observation and physical examination.
Organization of Groups:
Eight hundred mice divided into one control (C) and seven test groups (7 different test materials) of 100 each were utilized. The animals were housed ten to a cage in standard laboratory cages. Water was supplied in bottles with stainless steel drinking tubes. Feed was offered ad libitum.
Administration / exposure
- Route of administration:
- dermal
- Vehicle:
- not specified
- Details on exposure:
- Dosage:
Following a two-week laboratory observation period, the compound application was begun. The material was applied with a camel hair brush to the back of each animal three times weekly for the duration of the test using a different brush for each group. Prior to dosing, the hair was removed from the site with an electric clipper utilizing a #40 surgical blade. The animals were dosed three times per week for a period of 78 consecutive weeks. - Analytical verification of doses or concentrations:
- no
- Duration of treatment / exposure:
- 78 consecutive weeks.
- Frequency of treatment:
- 3 times per week.
- Post exposure period:
- None
Doses / concentrations
- Remarks:
- Doses / Concentrations:
15 mg/mouse
Basis:
other: test material
- No. of animals per sex per dose:
- 100
- Control animals:
- yes, concurrent no treatment
- Details on study design:
- Organization of Groups:
Eight hundred mice divided into one control (C) and seven test groups (7 different test materials) of 100 each were utilized.
Examinations
- Observations and examinations performed and frequency:
- Observations:
The animals were observed daily. Any untoward behavioral reactions or changes on the skin of the mice were noted. Separate records were kept on each mouse containing pertinent data regarding dates, skin reactions, dosage and quantity of material applied. After a suspected papilloma reached one mm in diameter, it was measured and its size recorded weekly. - Sacrifice and pathology:
- An autopsy was performed on All animals. The skin, internal organs and carcass were fixed in 10 percent buffered formalin. All skin lesions were examined histologically using hematoxylin arid eosin stain.
Results and discussion
Results of examinations
- Clinical signs:
- effects observed, treatment-related
- Description (incidence and severity):
- 26 animals died in the Automate Red B group. There was 74% survival.
- Mortality:
- mortality observed, treatment-related
- Description (incidence):
- 26 animals died in the Automate Red B group. There was 74% survival.
- Body weight and weight changes:
- not examined
- Food consumption and compound intake (if feeding study):
- not examined
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- not examined
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Organ weight findings including organ / body weight ratios:
- not examined
- Gross pathological findings:
- effects observed, treatment-related
- Description (incidence and severity):
- The hair and skin of animals in the Automate Red B group became red upon application of test material. The majority of animals in this group showed a light orange coloration of internal fatty tissue.
- Histopathological findings: neoplastic:
- effects observed, treatment-related
- Description (incidence and severity):
- Low incidence of spontaneous tumor (mammary) and a rather high incidence of lymphosarcomas (also a spontaneous tumor).
- Details on results:
- Mortality and Reactions:
No abnormal behavioral reactions or signs of systemic toxicity were noted. No growths were noted in the control group or the Automate Red B test group. The hair and skin of animals in the Automate Red B group became red upon application of test material. The majority of animals in the Automate Red Bgroup showed a light orange coloration of internal fatty tissue.
Histopathological Examination:
Histological examination of the organs and tissues of the treated mice revealed a low incidence of spontaneous tumors (mammary) and a rather high incidence of lymphosarcomas (also a spontaneous tumor). Since these were present in the control group, it was concluded that these are not related to an effect of the compound.
Applicant's summary and conclusion
- Conclusions:
- A carcinogenicity study was conducted in 100 Swiss white mice with Automate Red B and 100 control mice. The test compound was applied to the skin of the backs at a dose of 15 mg/mouse. This dose was applied three times weekly for 18 months. The control animals received nothing. No dermal lesions were observed in the test group. No abnormal behavioral reactions or signs of systemic toxicity were noted. No growths were noted in the control group or the Automate Red B test group. The hair and skin of animals in the Automate Red B group became red upon application of test material. The majority of animals in the Automate Red B group showed a light orange coloration of internal fatty tissue. Survival was 74% in the test group and 76% in the control group. Histological examination of the organs and tissues of the treated mice revealed a low incidence of spontaneous tumors (mammary) and a rather high incidence of lymphosarcomas (also a spontaneous tumor). Since these were present in the control group, it was concluded that these are not related to an effect of the compound.
- Executive summary:
A carcinogenicity study was conducted in 100 Swiss white mice with Automate Red B and 100 control mice. The test compound was applied to the skin of the backs at a dose of 15 mg/mouse. This dose was applied three times weekly for 18 months. The control animals received nothing. No dermal lesions were observed in the test group. No abnormal behavioral reactions or signs of systemic toxicity were noted. No growths were noted in the control group or the Automate Red B test group. The hair and skin of animals in the Automate Red B group became red upon application of test material. The majority of animals in the Automate Red B group showed a light orange coloration of internal fatty tissue. Survival was 74% in the test group and 76% in the control group. Histological examination of the organs and tissues of the treated mice revealed a low incidence of spontaneous tumors (mammary) and a rather high incidence of lymphosarcomas (also a spontaneous tumor). Since these were present in the control group, it was concluded that these are not related to an effect of the compound.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.